NANOPHASE TECHNOLOGIES CORPORATION (OTCMKTS:NANX) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01
Entry into a Material Definitive Agreement
On November 21, 2016, Nanophase Technologies Corporation (the
Company) and Roche Diagnostics GmbH (Roche) entered into the
Second Amendment (the Second Amendment) to the Supply Agreement
of March 3, 2006, as previously amended by the First Amendment
dated November 19, 2014, between the Company and Roche (as
previously amended, the Supply Agreement). The Second Amendment,
which is effective as of December1, 2016, sets forth the price
per kilogram that will be payable by Roche and/or its affiliates
to the Company for the Companys products, based on a non-binding
forecasted volume of products to be purchased by Roche in a given
calendar year. The Second Amendment also (i) revises the
definition of the term Affiliates, (ii) addresses the parties
agreements, responsibilities, obligations, cost allocation and
liability with respect to foreign trade control and customs
matters and (iii) adds a section regarding the Companys
compliance with those laws and regulations related to safety,
health and environmental matters that are applicable to the
manufacture of the Companys products at its manufacturing site,
its respect of human rights, and its compliance, and its
suppliers compliance, with the Roche Supplier Code of Conduct,
which section provides Roche with the right to terminate the
Supply Agreement at any time by written notice to the Company in
the case of non-compliance.
All other terms and conditions in the Supply Agreement as in
effect immediately prior to the Second Amendment remain in full
force and effect thereafter. The foregoing description of the
Second Amendment does not purport to be complete and is qualified
in its entirety by reference to the text of the Second Amendment,
which is filed, with confidential portions redacted, as Exhibit
10.1 hereto and is incorporated herein by reference.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits:
The following item is filed as an exhibit to this Current Report
on Form 8-K:
Exhibit No. | Exhibit |
10.1* |
Second Amendment to the Supply Agreement, entered into on November 21, 2016, between the Company and Roche Diagnostics GmbH |
__________
* Confidential treatment has been requested with respect to
certain portions of this exhibit. Omitted portions have been
filed separately with the Securities and Exchange Commission.
About NANOPHASE TECHNOLOGIES CORPORATION (OTCMKTS:NANX)
Nanophase Technologies Corporation is a materials and applications developer and commercial manufacturer with an integrated family of materials technologies. The Company produces engineered nano and sub-micron materials for use in a range of markets, including personal care, including sunscreens, architectural coatings, industrial coating applications, abrasion-resistant additives, plastics additives, medical diagnostics, energy, and a range of surface finishing technologies (polishing) applications, including optics. The technologies are designed to offer nanomaterial solutions for a targeted market or a specific customer application. The Company’s nanomaterials platform includes over two distinct manufacturing processes (Plasma Vapor Synthesis (PVS) and NanoArc Synthesis (NAS)) to make nanomaterials or nanoparticles. The Company’s products include Aluminum Oxide, Antimony Tin Oxide, Bismuth Oxide, Cerium Oxide, Iron Oxide and Zinc Oxide. NANOPHASE TECHNOLOGIES CORPORATION (OTCMKTS:NANX) Recent Trading Information
NANOPHASE TECHNOLOGIES CORPORATION (OTCMKTS:NANX) closed its last trading session down -0.060 at 0.670 with 4,398 shares trading hands.